EGFR and hepatocellular carcinoma: The stat3 signaling pathway, which may be activated by several growth factor receptors, such as EGFR and PDGFR (19–20), is known to be associated with the progression of HCC; thus, the effects of hSulf-1 on stat3 signaling must also be explored in HCC cells.